Mereo BioPharma Group plc Gains 32.26%
Tue, Dec 31, 2019 at 05:30 PM
Mereo BioPharma Group plc (MREO:NASDAQ) shot up at $3.28, representing a gain of 32.3%. On Mon 30 Dec 19, MREO:NASDAQ touched a New 2-Week Intraday High of $3. From Mon 09 Dec 19, the stock recorded 35.71% Up Days and 26.67% Green Days
The stock spiked on Fri 27 Dec 19 at $3.74 with a volume of 5M+.
About Mereo BioPharma Group plc (MREO:NASDAQ)
Mereo BioPharma Group PLC was incorporated and registered in England and Wales under the name Mereo BioPharma Group Limited on March 10, 2015. On June 3, 2016, the Company re-registered as a public company and changed its name to Mereo BioPharma Group PLC. The Company is a speciality biopharmaceutical company. The Company is principally engaged in the research and development of novel pharmaceuticals.
Top 10 Gainers:
- Spirit Realty Capital, Inc. (SRC:NYSE), 66.67%
- FuelCell Energy, Inc. (FCEL:NASDAQ), 49.4%
- Viveve Medical, Inc. (VIVE:NASDAQ), 46.51%
- Inpixon (INPX:NASDAQ), 43.61%
- BioXcel Therapeutics, Inc. (BTAI:NASDAQ), 40.35%
- Neovasc Inc. (NVCN:NASDAQ), 36.96%
- Mereo BioPharma Group plc (MREO:NASDAQ), 32.26%
- Lincoln Educational Services Corporation (LINC:NASDAQ), 25%
- Jaguar Health, Inc. (JAGX:NASDAQ), 23.02%
- Oncolytics Biotech Inc. (ONCY:NASDAQ), 23%